Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PARP1 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | XRCC6 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
mRNA | EPB41L1 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
mRNA | ZNF121 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | PPIL1 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
mRNA | CCAR1 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | MDN1 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | UBE2O | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | INPP5B | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
mRNA | TAF5L | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |